UF Scientist’s Parkinson’s Work Selected for Innovative Drug Development Effort
University of Florida chemist Matthew Disney, Ph.D., was selected for an ambitious two-year effort to move promising Parkinson’s disease discoveries to patients.
What the Trained Eye Cannot See: Detecting Movement Defects in Early-Stage Parkinson’s Disease
A technique that uses videos and machine learning to quantify motor symptoms in early-stage Parkinson’s disease could help reveal signs of the disease and other movement disorders earlier, which could lead to better treatment outcomes.
New Video Test for Parkinson’s Uses AI to Track How the Disease Is Progressing
A video-processing technique developed at the University of Florida that uses artificial intelligence will help neurologists better track the progression of Parkinson’s disease in patients, ultimately enhancing their care and quality of life.
UF-Led Researchers Link New Genetic Mutation to Increased Risk of Parkinson’s
New research by a University of Florida-led international team has revealed evidence linking a new genetic mutation to greater risk of developing Parkinson’s disease.
UF Neuroscientists Discover Biomarker With Potential To Aid Parkinson’s Diagnosis
University of Florida neuroscientists have developed a new assay, or test, to detect minute amounts of a protein called tyrosine hydroxylase in blood immune cells of Parkinson’s disease patients, a key finding to aid in the development of a blood test to help diagnose and guide treatment for the neurodegenerative disorder.
New AI Tool To Be Tested in NIH-Funded Study To Improve Diagnosis of Parkinson’s and Related Disorders
UF researchers will broadly test a new AI tool aimed at distinguishing the precise diagnosis for patients with early Parkinson’s disease or two related syndromes under a new $5 million grant from the National Institutes of Health.
